TY - JOUR
T1 - Successful nonmyeloablative bone marrow transplantation for leukocyte adhesion deficiency type I from an unrelated donor
AU - Tokunaga, Masahiro
AU - Miyamura, Koichi
AU - Ohashi, Haruhiko
AU - Ishiwada, Naruhiko
AU - Terakura, Seitaro
AU - Ikeguchi, Miyoko
AU - Kuwatsuka, Yachiyo
AU - Inamoto, Yoshihiro
AU - Oba, Taku
AU - Tsuchiya, Shigeru
AU - Kodera, Yoshihisa
PY - 2007/7
Y1 - 2007/7
N2 - Leukocyte adhesion deficiency type I (LAD-I) is an inherited immunodeficiency disorder caused by defective expression of the leukocyte integrins, namely, lymphocyte function-associated antigen 1, Mac-1, and p150,95, and is associated with obstructed cell adhesion, migration, and phagocytosis. Patients suffer from various bacterial or fungal infections and their prognoses are poor. The only curative treatment is hematopoietic stem cell transplantation. Conventional myeloablative transplantations have been performed, but with unsatisfactory results. We performed the first successful nonmyeloablative unrelated marrow transplantation for a 20-year-old female LAD-I patient, who suffered from recurrent and occasionally life-threatening infections such as cellulitis, gingivostomatitis, and sepsis. We adopted a preparative regimen with fludarabine, cyclophosphamide, and low-dose total-body irradiation, and tacrolimus and short-term methotrexate as immunosuppressants. This procedure was sufficiently immunosuppressive to obtain stable engraftment without remarkable complications, and graft-versus-host disease was controllable. Dramatic improvement of her disease was observed, supported by the normal expressions of integrins. Twenty one months after transplantation, she is well with a Karnofsky score of 100. Thus, nonmyeloablative transplantation is considered a feasible method for LAD-I.
AB - Leukocyte adhesion deficiency type I (LAD-I) is an inherited immunodeficiency disorder caused by defective expression of the leukocyte integrins, namely, lymphocyte function-associated antigen 1, Mac-1, and p150,95, and is associated with obstructed cell adhesion, migration, and phagocytosis. Patients suffer from various bacterial or fungal infections and their prognoses are poor. The only curative treatment is hematopoietic stem cell transplantation. Conventional myeloablative transplantations have been performed, but with unsatisfactory results. We performed the first successful nonmyeloablative unrelated marrow transplantation for a 20-year-old female LAD-I patient, who suffered from recurrent and occasionally life-threatening infections such as cellulitis, gingivostomatitis, and sepsis. We adopted a preparative regimen with fludarabine, cyclophosphamide, and low-dose total-body irradiation, and tacrolimus and short-term methotrexate as immunosuppressants. This procedure was sufficiently immunosuppressive to obtain stable engraftment without remarkable complications, and graft-versus-host disease was controllable. Dramatic improvement of her disease was observed, supported by the normal expressions of integrins. Twenty one months after transplantation, she is well with a Karnofsky score of 100. Thus, nonmyeloablative transplantation is considered a feasible method for LAD-I.
UR - http://www.scopus.com/inward/record.url?scp=34547625756&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547625756&partnerID=8YFLogxK
U2 - 10.1532/IJH97.06209
DO - 10.1532/IJH97.06209
M3 - Article
C2 - 17675274
AN - SCOPUS:34547625756
SN - 0925-5710
VL - 86
SP - 91
EP - 95
JO - International Journal of Hematology
JF - International Journal of Hematology
IS - 1
ER -